The Winship Cancer Institute (Winship) has solicited extensive Input from both external and internal advisory groups and leadership committees for the planning and evaluation of its current progress, continued advancement, and the establishment of future goals and objectives. In the last reporting period, Strategically composed internal and external committees have enabled Winship to elevate the science it performs. The internal and external mechanisms discussed in this section provide essential guidance on all aspects of Winship, and include the following groups: External Planning and Evaluation: External Advisory Board (EAB), External Administrative Advisory Board, and External Clinical Trials Advisory Boards;and Internal Planning and Evaluation: Winship Internal Advisory Board, Winship Executive Committee, Scientific Research Council, Shared Resource Directors Meeting, Shared Resource Oversight Committee, Membership Committee, Shared Resource Allocation Committee, Space Resource Allocation Committee, Administrative Council, and Winship Clinical Council. Guidance and direction gathered from these many committees has been critical to the advancement of the Winship Cancer Institute. The input from these groups played a major role in the development of the 2010-2015 Winship Strategic Plan. That document has provided Winship a roadmap during the funding cycle proposed in this application. The funds requested in addition to committed institutional funds will provide support for these important advisory endeavors.
The Planning and Evaluation process has been instrumental in Winship's many successes. Each advisory structure works to ensure that Winship's priorities are understood and strategically managed to allow the cancer center to continue to develop and achieve a comprehensive set of goals.
|Havel, L S; Kline, E R; Salgueiro, A M et al. (2015) Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity. Oncogene 34:1979-90|
|Forghani, Parvin; Khorramizadeh, Mohammad R; Waller, Edmund K (2014) Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer. Cancer Med 3:215-24|
|Smith, Alicia K; Conneely, Karen N; Pace, Thaddeus W W et al. (2014) Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy. Brain Behav Immun 38:227-36|
|Ha, Shin-Woo; Weitzmann, M Neale; Beck Jr, George R (2014) Bioactive silica nanoparticles promote osteoblast differentiation through stimulation of autophagy and direct association with LC3 and p62. ACS Nano 8:5898-910|
|Nooka, Ajay K; Johnson, Heather R; Kaufman, Jonathan L et al. (2014) Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20:852-7|
|Capaldo, Christopher T; Farkas, Attila E; Hilgarth, Roland S et al. (2014) Proinflammatory cytokine-induced tight junction remodeling through dynamic self-assembly of claudins. Mol Biol Cell 25:2710-9|
|Sullivan, Harold C; Oprea-Ilies, Gabriela; Adams, Amy L et al. (2014) Triple-negative breast carcinoma in African American and Caucasian women: clinicopathology, immunomarkers, and outcome. Appl Immunohistochem Mol Morphol 22:17-23|
|Brodie, Seth A; Li, Ge; El-Kommos, Adam et al. (2014) Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer. Cancer Prev Res (Phila) 7:351-61|
|Wang, Hongyan; Wang, Ya (2014) Heavier ions with a different linear energy transfer spectrum kill more cells due to similar interference with the Ku-dependent DNA repair pathway. Radiat Res 182:458-61|
|Jurchenko, Carol; Chang, Yuan; Narui, Yoshie et al. (2014) Integrin-generated forces lead to streptavidin-biotin unbinding in cellular adhesions. Biophys J 106:1436-46|
Showing the most recent 10 out of 49 publications